178 related articles for article (PubMed ID: 9636510)
1. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
Copley JB; Staffeld C; Lindberg J; Hansen A; Bailey C; Anand R; Van Veldhuisen P
Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510
[No Abstract] [Full Text] [Related]
2. Improvement of nephrotoxicity, hypertension, and lipid metabolism after conversion of kidney transplant recipients from cyclosporine to tacrolimus.
Friemann S; Feuring E; Padberg W; Ernst W
Transplant Proc; 1998 Jun; 30(4):1240-2. PubMed ID: 9636504
[No Abstract] [Full Text] [Related]
3. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
[TBL] [Abstract][Full Text] [Related]
4. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
Colak T; Karakayali H; Yagmurdur MC; Moray G
Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321
[No Abstract] [Full Text] [Related]
5. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
Manu M; Tanabe K; Tokumoto T; Ishikawa N; Shimizu T; Okuda H; Ito S; Shimmura H; Inui M; Harano M; Shiroyanagi Y; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1736-8. PubMed ID: 11119912
[No Abstract] [Full Text] [Related]
6. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function.
Perrea DN; Moulakakis KG; Poulakou MV; Vlachos IS; Nikiteas N; Kostakis A
Int Urol Nephrol; 2008; 40(2):521-7. PubMed ID: 17978855
[TBL] [Abstract][Full Text] [Related]
7. Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study.
McCune TR; Thacker LR II; Peters TG; Mulloy L; Rohr MS; Adams PA; Yium J; Light JA; Pruett T; Gaber AO; Selman SH; Jonsson J; Hayes JM; Wright FH; Armata T; Blanton J; Burdick JF
Transplantation; 1998 Jan; 65(1):87-92. PubMed ID: 9448150
[TBL] [Abstract][Full Text] [Related]
8. Improved attainment of NKF classified lipid target levels after conversion from cyclosporine to tacrolimus in renal graft recipients.
Pohanka E; Margreiter R; Sparacino V; Sperschneider H;
Transplant Proc; 2005 May; 37(4):1874-6. PubMed ID: 15919490
[TBL] [Abstract][Full Text] [Related]
9. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
Montagnino G; Tarantino A; Aroldi A; Banfi G; Cesana B; Ponticelli C
Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
[No Abstract] [Full Text] [Related]
10. Dislipidemia at different immunosuppressive protocols.
Zezina L; Rosental R
Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
[No Abstract] [Full Text] [Related]
11. Beneficial effects of converting liver transplant recipients from cyclosporine to tacrolimus on blood pressure, serum lipids, and weight.
Neal DA; Gimson AE; Gibbs P; Alexander GJ
Liver Transpl; 2001 Jun; 7(6):533-9. PubMed ID: 11443583
[TBL] [Abstract][Full Text] [Related]
12. Conversion from cyclosporine A to tacrolimus after kidney transplantation due to hyperlipidemia.
Kohnle M; Zimmermann U; Lütkes P; Albrecht KH; Philipp T; Heemann U
Transpl Int; 2000; 13 Suppl 1():S345-8. PubMed ID: 11112029
[TBL] [Abstract][Full Text] [Related]
13. Do blood pressure and arterial wall properties change after conversion from cyclosporine to tacrolimus?
Gelens MA; Christiaans MH; v Hooff JP
Transplant Proc; 2005 May; 37(4):1900-1. PubMed ID: 15919498
[TBL] [Abstract][Full Text] [Related]
14. Effects of fish oil in cyclosporine-treated renal transplant recipients.
Santos J; Queirós J; Silva F; Cabrita A; Rodrigues A; Henriques AC; Sarmento AM; Pereira MC; Guimarães S
Transplant Proc; 2000 Dec; 32(8):2605-8. PubMed ID: 11134724
[No Abstract] [Full Text] [Related]
15. Incidence of new-onset hypercholesterolemia in renal transplant patients treated with FK506 or cyclosporine.
Satterthwaite R; Aswad S; Sunga V; Shidban H; Bogaard T; Asai P; Khetan U; Akra I; Mendez RG; Mendez R
Transplantation; 1998 Feb; 65(3):446-9. PubMed ID: 9484771
[TBL] [Abstract][Full Text] [Related]
16. Randomized conversion from cyclosporine to tacrolimus in renal transplant patients: improved lipid profile and unchanged plasma homocysteine levels.
Artz MA; Boots JM; Ligtenberg G; Roodnat JI; Christiaans MH; Hené RJ; Blom HJ; Demacker PN; Hilbrands LB
Transplant Proc; 2002 Aug; 34(5):1793-4. PubMed ID: 12176579
[No Abstract] [Full Text] [Related]
17. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens.
Law YM; Yim R; Agatisa P; Boyle GJ; Miller SA; Lawrence K; Webber SA
J Heart Lung Transplant; 2006 Mar; 25(3):276-82. PubMed ID: 16507419
[TBL] [Abstract][Full Text] [Related]
18. Conversion to tacrolimus in hyperlipidemic patients.
Friemann S; Stopp K; Christ B; Weimer R; Padberg W; Ernst W
Transplant Proc; 1999 Nov; 31(7A):41S-43S. PubMed ID: 10576042
[No Abstract] [Full Text] [Related]
19. New onset dyslipidemia after renal transplantation: is there a difference between tacrolimus and cyclosporine?
Deleuze S; Garrigue V; Delmas S; Chong G; Swarcz I; Cristol JP; Mourad G
Transplant Proc; 2006 Sep; 38(7):2311-3. PubMed ID: 16980075
[TBL] [Abstract][Full Text] [Related]
20. Serum cholesterol changes in long-term survivors of liver transplantation: a comparison between cyclosporine and tacrolimus therapy.
Charco R; Cantarell C; Vargas V; Capdevila L; Lázaro JL; Hidalgo E; Murio E; Margarit C
Liver Transpl Surg; 1999 May; 5(3):204-8. PubMed ID: 10226111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
